Latest Financial Management News

EverGreen Lithium’s 2024 drilling at the Bynoe Project confirms anomalous gold mineralisation but no significant lithium, prompting a strategic pivot to expanded gold and pegmatite exploration in 2025.

TZ Limited reported a challenging Q3 FY2025 with a $1.03 million net cash outflow amid US tariff disruptions but strengthened its SaaS base through the Keyvision acquisition, positioning for a rebound and growth in FY2026.

Triton Minerals has initiated legal proceedings after a key payment default in its sale of Mozambique graphite assets, while advancing exploration at its new Aucu copper/gold project.

Clarity Pharmaceuticals reports a robust cash position and strategic refocus on its lead prostate cancer asset, Cu-SAR-bisPSMA, supported by multiple FDA Fast Track designations and advancing clinical trials.

Evolution Energy Minerals initiates a strategic review and cost-cutting at its Chilalo graphite project while progressing a farm-out deal for its Chikundu Cu-Pb-Zn VHMS prospect with Oscillate plc.

Audio Pixels Holdings Limited reports significant progress in its MEMS fabrication and ASIC development, targeting wafer completion by Q2 2025 while managing funding and ASX suspension challenges.

Otto Energy reported steady revenue of US$5.2 million in Q1 2025 despite a 9% production decline, offset by higher commodity prices and a significant insurance claim. The company also strengthened its cash position and reduced operating costs.

Corella Resources has successfully completed a fully underwritten rights issue raising $935,487, positioning the company to advance exploration at its Tampu Project and consider new opportunities.

Asra Minerals has completed a comprehensive target generation exercise at its Leonora Gold Projects, identifying 26 priority drill-ready gold targets and securing regulatory approval to commence drilling in Q2 2025. The company also strengthened its balance sheet with a $3 million placement and asset sale proceeds.

Vectus Biosystems advances its lead fibrosis drug VB0004 with validated Phase I safety data and strategic cost reductions, while actively pursuing licensing partnerships in China.

NoviqTech has advanced its blockchain-based sustainability solutions, pioneering real-world asset tokenisation and expanding its investor base through OTCQB trading in the US.

International Graphite's March 2025 quarterly report highlights strong geopolitical tailwinds and government backing for its Springdale Graphite Project and Collie processing facilities, positioning the company as a key player in the critical minerals supply chain.